Search research articles
Contact Us
Filters
Showing results (11-20 of 200) with videos related to
Page
of 20
Sort By:
The Journal of Biological Chemistry
|
September 25, 1977
Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII
B N Bouma, J H Griffin
Journal of Thrombosis and Haemostasis : JTH
|
July 23, 2003
Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U)
B N Bouma, J C M Meijers
Journal of Thrombosis and Haemostasis : JTH
|
February 8, 2006
Unraveling the mystery of von Willebrand factor
B N Bouma, J A Van Mourik
Scandinavian Journal of Rheumatology
|
January 1, 1987
The prevalence and clinical associations of the lupus anticoagulant in systemic lupus erythematosus
R H Derksen, B N Bouma, L Kater
The Journal of Biological Chemistry
|
September 10, 1978
Human blood coagulation factor IX. Purification, properties, and mechanism of activation by activated factor XI
B Osterud, B N Bouma, J H Griffin
Scandinavian Journal of Clinical and Laboratory Investigation
|
June 1, 1971
Typing of fibrinogen degradation products in urine in various clinical disorders
B N Bouma, U Hedner, I M Nilsson
Thrombosis Research
|
July 1, 1974
Characterization and ATPase activity of human platelet actomyosin
J Lindemans, B N Bouma, J J Sixma
Scandinavian Journal of Rheumatology
|
January 1, 1986
The association between the lupus anticoagulant and cerebral infarction in systemic lupus erythematosus
R H Derksen, B N Bouma, L Kater
Arthritis and Rheumatism
|
May 1, 1986
The striking association between lupus anticoagulant and fetal loss in systemic lupus erythematosus patients
R H Derksen, B N Bouma, L Kater
Acta Chirurgica Scandinavica. Supplementum
|
January 1, 1982
Determination of prekallikrein using an amidolytic assay in plasma samples of critically ill patients
E S Kalter, R A Vlooswijk, B N Bouma
Page
of 20
Search research articles
Search
Showing results (11-20 of 200) with videos related to
Sort By:
Page
of 20
The Journal of Biological Chemistry
|
September 25, 1977
Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII
B N Bouma, J H Griffin
Journal of Thrombosis and Haemostasis : JTH
|
July 23, 2003
Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U)
B N Bouma, J C M Meijers
Journal of Thrombosis and Haemostasis : JTH
|
February 8, 2006
Unraveling the mystery of von Willebrand factor
B N Bouma, J A Van Mourik
Scandinavian Journal of Rheumatology
|
January 1, 1987
The prevalence and clinical associations of the lupus anticoagulant in systemic lupus erythematosus
R H Derksen, B N Bouma, L Kater
The Journal of Biological Chemistry
|
September 10, 1978
Human blood coagulation factor IX. Purification, properties, and mechanism of activation by activated factor XI
B Osterud, B N Bouma, J H Griffin
Scandinavian Journal of Clinical and Laboratory Investigation
|
June 1, 1971
Typing of fibrinogen degradation products in urine in various clinical disorders
B N Bouma, U Hedner, I M Nilsson
Thrombosis Research
|
July 1, 1974
Characterization and ATPase activity of human platelet actomyosin
J Lindemans, B N Bouma, J J Sixma
Scandinavian Journal of Rheumatology
|
January 1, 1986
The association between the lupus anticoagulant and cerebral infarction in systemic lupus erythematosus
R H Derksen, B N Bouma, L Kater
Arthritis and Rheumatism
|
May 1, 1986
The striking association between lupus anticoagulant and fetal loss in systemic lupus erythematosus patients
R H Derksen, B N Bouma, L Kater
Acta Chirurgica Scandinavica. Supplementum
|
January 1, 1982
Determination of prekallikrein using an amidolytic assay in plasma samples of critically ill patients
E S Kalter, R A Vlooswijk, B N Bouma
Page
of 20